Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06073808 · ClinicalTrials.gov registry record · NA
The Role of Amnion Membrane Allografts in Nipple Preservation
A NA study, sponsored by Stanford University.
- Not yet
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT06073808: Clinical Trial NA study, sponsored by Stanford University.
NCT06073808 is a NA study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06073808, a NA study, has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The overall objective of this proposal is to conduct a randomized-controlled study to determine whether treatment with dehydrated human amnion/chorion membrane (dHACMs) allografts can improve NAC viability in patients undergoing nipple sparing mastectomy (NSM). dHACM allografts are commercially available tissue membranes with biocompatible extracellular matrix and growth factors that have been shown to improve wound healing in patients with chronic and lower extremity wounds. To date, no study has evaluated the impact of dHACMs on NAC preservation following NSM. Investigators hypothesize that subareolar surgical implantation of dHACM allografts at time of NSM will reduce NAC necrosis and improve viability.
Interventions
- DEVICE Control Device
- DEVICE AmnioFix dehydrated Human Amnion/Chorion Membrane Allograft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2026-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06073808
The ClinicalTrials.gov registry entry for NCT06073808 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control Device is the first listed.
NCT06073808 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06073808 about?
NCT06073808 is a clinical study titled "The Role of Amnion Membrane Allografts in Nipple Preservation". The overall objective of this proposal is to conduct a randomized-controlled study to determine whether treatment with dehydrated human amnion/chorion membrane (dHACMs) allografts can improve NAC viability in patients undergoing nipple sparing mastectomy (NSM). dHACM allografts are commercially avai...
What is the current status of trial NCT06073808?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-06-01. Estimated completion is 2026-09.
What interventions are being tested in trial NCT06073808?
The interventions under investigation include: Control Device (DEVICE), AmnioFix dehydrated Human Amnion/Chorion Membrane Allograft (DEVICE).
Who is sponsoring clinical trial NCT06073808?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.